Alnylam Pharmaceuticals Inc. shares fell more than 8% premarket on Thursday after advisers to the U.S. Food and Drug Administration on Wednesday weighed the...
Alnylam Pharmaceuticals Inc.
shares fell more than 8% premarket on Thursday after advisers to the U.S. Food and Drug Administration on Wednesday weighed the risks and benefits of the company’s treatment for a serious heart condition known as ATTR-CM. The FDA advisory committee voted 9 to 3 that the benefits of the treatment, Onpattro, outweigh its risks in patients with ATTR-CM, but the committee’s comments suggest that the drug’s label may be limited, analysts say.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Alnylam Pharmaceuticals’ stock to be halted Wednesday as FDA advisory panel reviews treatment for the Cardiomyopathy of ATTR AmyloidosisAlnylam Pharmaceuticals Inc. said Wednesday its stock will be halted on Nasdaq through the day as a regulatory advisory committee will meet to review its new...
Leer más »
Rocket Pharmaceuticals, Moderna rise; American Airlines, Spirit Airlines fall, Wednesday, 9/13/2023Stocks that are trading heavily or have substantial price changes on Wednesday: Rocket Pharmaceuticals, Moderna rise; American Airlines, Spirit Airlines fall.
Leer más »
Ford stock boosted by UBS upgrade, Nio shares drop on probe, and other stocks on the moveFord, General Motors, Apple and Rocket Pharmaceuticals are active.
Leer más »
Berkshire Hathaway Inc. Cl B stock rises Tuesday, outperforms marketShares of Berkshire Hathaway Inc. Cl B inched 0.62% higher to $367.78 Tuesday, on what proved to be an all-around dismal trading session for the stock...
Leer más »
Alphabet Inc. Cl A stock falls Tuesday, underperforms marketShares of Alphabet Inc. Cl A shed 1.15% to $135.34 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...
Leer más »
Apple Inc. stock outperforms competitors despite losses on the dayShares of Apple Inc. slid 1.71% to $176.30 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite...
Leer más »